Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew R Blight

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Therapeutic Advances in Neurological Disorders|June 23, 2011
Treatment of walking impairment in multiple sclerosis with dalfampridineAndrew R Blight
Nature Neuroscience|February 26, 2004
Just one word: plasticityAndrew R Blight
Nature Neuroscience|October 31, 2002
Miracles and molecules--progress in spinal cord repairAndrew R Blight
Annals of Neurology|February 1, 2011
4-Aminopyridine: new life for an old drug. ReplyRon Cohen, Andrew R Blight
Degenerative Neurological and Neuromuscular Disease|March 21, 2019
Walking impairment in patients with multiple sclerosis - a new therapeutic approach and clinical potential of dalfampridine extended release tabletsHerbert R Henney, Andrew R Blight
Journal of Neurotrauma|April 25, 2006
Clinical trials in spinal cord injuryAndrew R Blight, Mark H Tuszynski
Clinical Therapeutics|March 24, 2009
Pharmacokinetics of 14C-radioactivity after oral intake of a single dose of 14C-labeled fampridine (4-aminopyridine) in healthy volunteersAndrew R Blight, Herbert R Henney
Archives of Drug Information|November 17, 2009
Effects of 4-Aminopyridine on Cloned hERG Channels Expressed in Mammalian CellsMuthukrishnan Renganathan, Serguei Sidach, Andrew R Blight
Annals of the New York Academy of Sciences|August 27, 2014
Development of dalfampridine, a novel pharmacologic approach for treating walking impairment in multiple sclerosisAndrew R Blight, Herbert R Henney, Ron Cohen
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 8, 2011
Effect of food on the single-dose pharmacokinetics and tolerability of dalfampridine extended-release tablets in healthy volunteersHerbert R Henney, Bonnie Faust, Andrew R Blight
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Therapeutic Advances in Neurological Disorders|June 23, 2011
Treatment of walking impairment in multiple sclerosis with dalfampridineAndrew R Blight
Nature Neuroscience|February 26, 2004
Just one word: plasticityAndrew R Blight
Nature Neuroscience|October 31, 2002
Miracles and molecules--progress in spinal cord repairAndrew R Blight
Annals of Neurology|February 1, 2011
4-Aminopyridine: new life for an old drug. ReplyRon Cohen, Andrew R Blight
Degenerative Neurological and Neuromuscular Disease|March 21, 2019
Walking impairment in patients with multiple sclerosis - a new therapeutic approach and clinical potential of dalfampridine extended release tabletsHerbert R Henney, Andrew R Blight
Journal of Neurotrauma|April 25, 2006
Clinical trials in spinal cord injuryAndrew R Blight, Mark H Tuszynski
Clinical Therapeutics|March 24, 2009
Pharmacokinetics of 14C-radioactivity after oral intake of a single dose of 14C-labeled fampridine (4-aminopyridine) in healthy volunteersAndrew R Blight, Herbert R Henney
Archives of Drug Information|November 17, 2009
Effects of 4-Aminopyridine on Cloned hERG Channels Expressed in Mammalian CellsMuthukrishnan Renganathan, Serguei Sidach, Andrew R Blight
Annals of the New York Academy of Sciences|August 27, 2014
Development of dalfampridine, a novel pharmacologic approach for treating walking impairment in multiple sclerosisAndrew R Blight, Herbert R Henney, Ron Cohen
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 8, 2011
Effect of food on the single-dose pharmacokinetics and tolerability of dalfampridine extended-release tablets in healthy volunteersHerbert R Henney, Bonnie Faust, Andrew R Blight
Pageof 4